Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies

Epidemiological studies suggest that higher serum 25-hydroxyvitamin D is associated with lower risk for several cancers, including breast, prostate, colorectal, and lung cancers. To mitigate confounding, genetic instrumental variables (IVs) have been used to estimate causal associations between 25-h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawler, Thomas, Warren Andersen, Shaneda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865859/
https://www.ncbi.nlm.nih.gov/pubmed/36678292
http://dx.doi.org/10.3390/nu15020422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865859/
https://www.ncbi.nlm.nih.gov/pubmed/36678292
http://dx.doi.org/10.3390/nu15020422

Ejemplares similares